Displaying 1 - 12 of 19
Immune-Mediated and Cholestatic Diseases

Gilead: Creating change today: Lowering risk, lowering burden of PBC in practice (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Gilead: Creating change today: Lowering risk, lowering burden of PBC (Complete Session)

Webcasts
View
Viral Hepatitis

Gilead: AChievaBle toDay: For all patients with viral hepatitis (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity
Obesity: what do we need to know and why?

Obesity: what do we need to know and why?

Webcasts
View
Metabolism, Alcohol & Toxicity
Discussion

Discussion

Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction

Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity
Targeting obesity as a metabolic treatment approach in NAFLD/NASH

Targeting obesity as a metabolic treatment approach in NAFLD/NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Treatment strategies for improvement of NAFLD/NASH

Treatment strategies for improvement of NAFLD/NASH

Webcasts
View
Viral Hepatitis
A new beginning in hepatitis delta

A new beginning in hepatitis delta

Webcasts
View
Viral Hepatitis
A new paradigm for patients with hepatitis delta

A new paradigm for patients with hepatitis delta

Webcasts
View
Viral Hepatitis
Re-writing the treatment of hepatitis delta (PART 1)

Re-writing the treatment of hepatitis delta (PART 1)

Webcasts
View
Viral Hepatitis
Re-writing the treatment of hepatitis delta (PART 2)

Re-writing the treatment of hepatitis delta (PART 2)

Webcasts
View
Displaying 1 - 12 of 19